secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001193125-25-172192
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus enters $400M credit facility to refinance existing debt
-----------------------------------------------------------------

- $100M revolving credit facility and $300M term loan A facility, maturing July 31, 2030.
- Initial interest rate: Term SOFR + 2.50% margin, subject to performance grid (1.75%-2.75%).
- $30M drawn on revolver at closing; proceeds used to refinance existing 2019 credit facilities.
- Financial covenants: max total net leverage ratio 4.00x (step down to 3.50x), min interest coverage 2.50x.
- Facility secured by substantially all assets; includes $7.5M L/C and $7.5M swingline subfacilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000119312525172192/0001193125-25-172192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000119312525172192/d865758d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-172192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer